Shijia Zhang1, Sayeed Ikramuddin2, Heather C Beckwith1, Adam C Sheka2, Keith M Wirth2, Anne H Blaes3. 1. Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, 420 Delaware Street, SE, MMC 480, Minneapolis, MN, 55455, USA. 2. Department of Surgery, University of Minnesota, Minneapolis, MN, USA. 3. Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, 420 Delaware Street, SE, MMC 480, Minneapolis, MN, 55455, USA. blaes004@umn.edu.
Abstract
BACKGROUND: Excess body weight has been associated with worsening breast cancer survival. While bariatric surgery has been associated with less incident of breast cancer, the role that bariatric surgery plays after breast cancer diagnosis in terms of both feasibility and in preventing breast cancer recurrence is unclear. METHODS: We report the outcomes of 13 individuals who underwent bariatric surgery after definitive breast cancer treatment at a single institution. RESULTS: Thirteen females diagnosed with breast cancer (69.2% stage I, 23.1% stage II) at a median age of 42 years received bariatric surgery between 2001 and 2017. The median age of bariatric surgery was 52 years. Of the 13 patients, 46.2% underwent laparoscopic Roux-en-Y gastric bypass and 38.5% laparoscopic sleeve gastrectomy. The median time from breast cancer treatment to bariatric surgery was 3 years. The procedures were well tolerated. One female developed an abdominal wall hematoma. The average weight loss after 1 year and 2 years was 28.1% and 28.2%, respectively. There was a single breast cancer recurrence with a median follow-up of 11.7 years after breast cancer diagnosis and 5.3 years after bariatric surgery. CONCLUSIONS: Bariatric surgery after breast cancer treatment is feasible and well tolerated. Prospective trials evaluating bariatric surgery in obese breast cancer survivors should be considered.
BACKGROUND: Excess body weight has been associated with worsening breast cancer survival. While bariatric surgery has been associated with less incident of breast cancer, the role that bariatric surgery plays after breast cancer diagnosis in terms of both feasibility and in preventing breast cancer recurrence is unclear. METHODS: We report the outcomes of 13 individuals who underwent bariatric surgery after definitive breast cancer treatment at a single institution. RESULTS: Thirteen females diagnosed with breast cancer (69.2% stage I, 23.1% stage II) at a median age of 42 years received bariatric surgery between 2001 and 2017. The median age of bariatric surgery was 52 years. Of the 13 patients, 46.2% underwent laparoscopic Roux-en-Y gastric bypass and 38.5% laparoscopic sleeve gastrectomy. The median time from breast cancer treatment to bariatric surgery was 3 years. The procedures were well tolerated. One female developed an abdominal wall hematoma. The average weight loss after 1 year and 2 years was 28.1% and 28.2%, respectively. There was a single breast cancer recurrence with a median follow-up of 11.7 years after breast cancer diagnosis and 5.3 years after bariatric surgery. CONCLUSIONS: Bariatric surgery after breast cancer treatment is feasible and well tolerated. Prospective trials evaluating bariatric surgery in obese breast cancer survivors should be considered.
Entities:
Keywords:
Bariatric surgery; Breast cancer; Recurrence; Weight loss
Authors: Amy Berrington de Gonzalez; Patricia Hartge; James R Cerhan; Alan J Flint; Lindsay Hannan; Robert J MacInnis; Steven C Moore; Geoffrey S Tobias; Hoda Anton-Culver; Laura Beane Freeman; W Lawrence Beeson; Sandra L Clipp; Dallas R English; Aaron R Folsom; D Michal Freedman; Graham Giles; Niclas Hakansson; Katherine D Henderson; Judith Hoffman-Bolton; Jane A Hoppin; Karen L Koenig; I-Min Lee; Martha S Linet; Yikyung Park; Gaia Pocobelli; Arthur Schatzkin; Howard D Sesso; Elisabete Weiderpass; Bradley J Willcox; Alicja Wolk; Anne Zeleniuch-Jacquotte; Walter C Willett; Michael J Thun Journal: N Engl J Med Date: 2010-12-02 Impact factor: 91.245
Authors: Marco Colleoni; Zhuoxin Sun; Karen N Price; Per Karlsson; John F Forbes; Beat Thürlimann; Lorenzo Gianni; Monica Castiglione; Richard D Gelber; Alan S Coates; Aron Goldhirsch Journal: J Clin Oncol Date: 2016-01-19 Impact factor: 44.544
Authors: Daniel P Schauer; Heather Spencer Feigelson; Corinna Koebnick; Bette Caan; Sheila Weinmann; Anthony C Leonard; J David Powers; Panduranga R Yenumula; David E Arterburn Journal: Ann Surg Date: 2019-01 Impact factor: 12.969
Authors: Pamela J Goodwin; Roanne J Segal; Michael Vallis; Jennifer A Ligibel; Gregory R Pond; André Robidoux; George L Blackburn; Brian Findlay; Julie R Gralow; Som Mukherjee; Mark Levine; Kathleen I Pritchard Journal: J Clin Oncol Date: 2014-06-16 Impact factor: 44.544
Authors: Sayeed Ikramuddin; Judith Korner; Wei-Jei Lee; Avis J Thomas; John E Connett; John P Bantle; Daniel B Leslie; Qi Wang; William B Inabnet; Robert W Jeffery; Keong Chong; Lee-Ming Chuang; Michael D Jensen; Adrian Vella; Leaque Ahmed; Kumar Belani; Charles J Billington Journal: JAMA Date: 2018-01-16 Impact factor: 56.272
Authors: D S M Chan; A R Vieira; D Aune; E V Bandera; D C Greenwood; A McTiernan; D Navarro Rosenblatt; I Thune; R Vieira; T Norat Journal: Ann Oncol Date: 2014-04-27 Impact factor: 32.976
Authors: Lars Sjöström; Kristina Narbro; C David Sjöström; Kristjan Karason; Bo Larsson; Hans Wedel; Ted Lystig; Marianne Sullivan; Claude Bouchard; Björn Carlsson; Calle Bengtsson; Sven Dahlgren; Anders Gummesson; Peter Jacobson; Jan Karlsson; Anna-Karin Lindroos; Hans Lönroth; Ingmar Näslund; Torsten Olbers; Kaj Stenlöf; Jarl Torgerson; Göran Agren; Lena M S Carlsson Journal: N Engl J Med Date: 2007-08-23 Impact factor: 91.245
Authors: Margaret S Bohm; Laura M Sipe; Madeline E Pye; Matthew J Davis; Joseph F Pierre; Liza Makowski Journal: Cancer Metastasis Rev Date: 2022-07-23 Impact factor: 9.237
Authors: Laura M Sipe; Mehdi Chaib; Emily B Korba; Heejoon Jo; Mary Camille Lovely; Brittany R Counts; Ubaid Tanveer; Jeremiah R Holt; Jared C Clements; Neena A John; Deidre Daria; Tony N Marion; Margaret S Bohm; Radhika Sekhri; Ajeeth K Pingili; Bin Teng; James A Carson; D Neil Hayes; Matthew J Davis; Katherine L Cook; Joseph F Pierre; Liza Makowski Journal: Elife Date: 2022-07-01 Impact factor: 8.713